IP Library Granted Patent US 10,912,739
Granted Patent B2
US 10,912,739 · App. 16/160,499 · Granted Feb 9, 2021

Hydrocolloid-based skin treatment

Inventor: Enrico Frezza (Stateline, NV)
Assignee: PEACE OUT INC.
A61K9/7007A61K8/0208A61K8/044A61K8/27A61K8/4913A61K8/671A61K9/0043A61K31/07A61K31/133A61K31/555A61K47/38A61L15/44A61L15/46A61L15/60A61Q19/00A61Q19/008A61K9/0014A61Q19/005A61Q19/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,912,739
App. No.
16/160,499
Granted
Feb 9, 2021
Kind
B2
Abstract

The present technology relates generally to devices for treatment of skin and skin conditions, as well as methods for preparing the devices and methods of treatment using the devices. Suitably, the devices comprise a hydrocolloid dressing and one or more active agents, wherein the amount of the active agent(s) does not reduce the absorption properties of the hydrocolloid dressing.

Claims (18)

1. A device for treatment of skin, consisting of:

a. a hydrocolloid having a thickness of about 0.005 inches to about 0.012 inches; and

b. active agents consisting of vitamin A and dimethylethanolamine and optionally zinc pyrrolidone associated with the hydrocolloid,

wherein the active agents are present at an amount so as to not reduce the absorption capability of the hydrocolloid.

2. The device of claim 1 , wherein the active agents are present at an amount of about 0.1% to about 10%.

3. The device of claim 1 , wherein the vitamin A and the dimethylethanolamine are each present at an amount of about 0.2% to about 0.7%.

4. The device of claim 3 , wherein the vitamin A and the dimethylethanolamine are each present at an amount of about 0.5%.

5. The device of claim 1 , wherein the hydrocolloid has a thickness of about 0.005 inches to about 0.011 inches.

6. The device of claim 1 , wherein the active agents consist of vitamin A and dimethylethanolamine, each of about 0.5%.

7. A method of treating a skin condition, comprising:

a. providing a device, the device consisting of:

i. a hydrocolloid dressing having a thickness of about 0.005 inches to about 0.012 inches; and

ii. active agents consisting of vitamin A and dimethylethanolamine and optionally zinc pyrrolidone associated with the hydrocolloid dressing,

wherein the active agents are present at an amount so as to not reduce the absorption capability of the hydrocolloid dressing;

b. applying the device to a skin surface; and

c. maintaining the device on the skin surface for a period of at least 1 hour, thereby treating the skin condition.

8. The method of claim 7 , wherein the skin condition is a clogged pore, and wherein the device is applied to a cheek, nose, forehead, or chin skin surface.

9. The method of claim 7 , wherein the method of treatment is repeated daily for a period of at least 3 days.

Assignments (2)
SECURITY AGREEMENT Recorded May 21, 2024
From: PEACE OUT, LLC
To: SG STONEGATE ASSET COMPANY I, LLC
Reel/Frame 067484/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2020
From: FREZZA, ENRICO
To: PEACE OUT INC.
Reel/Frame 054005/0898 →
Continuity (2)
Provisional Application 62572643 · Oct 16, 2017
Related Publication 20190111005A1 · Apr 18, 2019